Long Road Investment Counsel’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$774K Hold
2,200
0.3% 57
2025
Q4
$720K Hold
2,200
0.27% 56
2025
Q3
$621K Hold
2,200
0.22% 62
2025
Q2
$614K Hold
2,200
0.23% 60
2025
Q1
$685K Hold
2,200
0.27% 57
2024
Q4
$573K Hold
2,200
0.23% 60
2024
Q3
$709K Hold
2,200
0.28% 56
2024
Q2
$687K Hold
2,200
0.3% 55
2024
Q1
$626K Buy
+2,200
New +$644K 0.26% 56
2023
Q4
Sell
-2,200
Closed -$591K 70
2023
Q3
$591K Hold
2,200
0.29% 56
2023
Q2
$488K Hold
2,200
0.23% 57
2023
Q1
$532K Hold
2,200
0.26% 58
2022
Q4
$578K Hold
2,200
0.29% 57
2022
Q3
$496K Hold
2,200
0.27% 61
2022
Q2
$535K Hold
2,200
0.27% 60
2022
Q1
$532K Buy
+2,200
New +$505K 0.24% 62

Other funds holding AMGN

Long Road Investment Counsel's AMGN Position: Q1 2026 in Review

Long Road Investment Counsel held its Amgen (AMGN) position steady in Q1 2026 at 2,200 shares worth $774K. The position accounts for 0.3% of the portfolio, ranked #57.

Long Road Investment Counsel first reported a position in AMGN in Q1 2022 and has held it in 16 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Long Road Investment Counsel held 2,200 shares of Amgen worth $774K as of Q1 2026.
  • Long Road Investment Counsel left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.3% of Long Road Investment Counsel's portfolio in Q1 2026, its #57 holding.
  • Long Road Investment Counsel first reported a position in Amgen in Q1 2022 and has held it in 16 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Long Road Investment Counsel's 13F filing for Q1 2026, filed 8 May 2026.